Published in Ann Epidemiol on January 01, 2009
Primary gastrointestinal lymphoma. World J Gastroenterol (2011) 2.20
Epidemiology of cancer of the small intestine. World J Gastrointest Oncol (2011) 1.75
A review of duodenal metastases from squamous cell carcinoma of the cervix presenting as an upper gastrointestinal bleed. World J Surg Oncol (2011) 1.31
Clinical characteristics of small bowel tumors diagnosed by double-balloon endoscopy: KASID multi-center study. Dig Dis Sci (2011) 1.08
Immunohistochemical features of the gastrointestinal tract tumors. J Gastrointest Oncol (2012) 1.06
Body mass, tobacco smoking, alcohol drinking and risk of cancer of the small intestine--a pooled analysis of over 500,000 subjects in the Asia Cohort Consortium. Ann Oncol (2011) 1.03
Small intestinal cancer: a population-based study of incidence and survival patterns in the United States, 1992 to 2006. Cancer Epidemiol Biomarkers Prev (2010) 1.00
Utility of positron emission tomography/CT in the evaluation of small bowel pathology. Br J Radiol (2012) 1.00
Small bowel adenocarcinomas--existing evidence and evolving paradigms. Nat Rev Clin Oncol (2013) 0.99
Current advance in small bowel tumors. Clin Endosc (2011) 0.89
Small bowel bleeding: a comprehensive review. Gastroenterol Rep (Oxf) (2014) 0.89
Management of adenocarcinoma of the small intestine. Gastrointest Cancer Res (2009) 0.85
Preoperative endoscopic diagnosis of superficial non-ampullary duodenal epithelial tumors, including magnifying endoscopy. World J Gastroenterol (2015) 0.84
A large prospective study of risk factors for adenocarcinomas and malignant carcinoid tumors of the small intestine. Cancer Causes Control (2013) 0.84
Postoperation of cervical cancer with intestine metastasis: a case report and literature review. World J Surg Oncol (2016) 0.79
Clinicopathologic features and prognosis of duodenal adenocarcinoma and comparison with ampullary and pancreatic ductal adenocarcinoma. Hum Pathol (2013) 0.78
Adenocarcinoma with adenoma in the jejunum suggesting an adenoma-carcinoma sequence in the small bowel: A case report. Oncol Lett (2014) 0.76
Gastric Adenocarcinoma in the Duodenal Stump 40 Years After a Billroth II Partial Gastrectomy for Benign Indications. Gastrointest Cancer Res (2012) 0.75
Unusual Metastasis from Carcinoma Cervix. J Obstet Gynaecol India (2015) 0.75
Adenocarcinoma of the small bowel in a patient with occlusive Crohn's disease. World J Gastrointest Oncol (2012) 0.75
Surgical Strategy and Outcomes in Duodenal Gastrointestinal Stromal Tumor. Ann Surg Oncol (2016) 0.75
Genetic risks and familial associations of small bowel carcinoma. World J Gastrointest Oncol (2016) 0.75
Untreated celiac disease in a patient with dermatitis herpetiformis leading to a small bowel carcinoma. Case Rep Gastroenterol (2012) 0.75
NonHodgkin's Lymphoma with Peritoneal Localization. Case Rep Gastrointest Med (2014) 0.75
Mucinous phenotype and CD10 expression of primary adenocarcinoma of the small intestine. World J Gastroenterol (2015) 0.75
Comparison of abdominal adiposity and overall obesity in relation to risk of small intestinal cancer in a European Prospective Cohort. Cancer Causes Control (2016) 0.75
Most small bowel cancers are revealed by a complication. Einstein (Sao Paulo) (2015) 0.75
Intra Luminal Metastasis to Duodenum: A Histological Surprise. J Clin Diagn Res (2016) 0.75
Small bowel malignancy in patients undergoing capsule endoscopy at a tertiary care academic center: Case series and review of the literature. Endosc Int Open (2017) 0.75
Microarray-based cytogenetic profiling reveals recurrent and subtype-associated genomic copy number aberrations in feline sarcomas. Chromosome Res (2009) 0.75
Incidence of, phenotypes of and survival from small bowel cancer in Denmark, 1994-2010: a population-based study. J Gastroenterol (2016) 0.75
Cancer statistics, 2008. CA Cancer J Clin (2008) 86.74
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature (2001) 33.12
The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut (2001) 10.07
Gut flora in health and disease. Lancet (2003) 9.85
Microbial influences in inflammatory bowel diseases. Gastroenterology (2008) 9.20
Mucosal flora in inflammatory bowel disease. Gastroenterology (2002) 8.42
Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol (2008) 7.65
Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat Genet (1998) 7.36
Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology (2000) 5.40
CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet (2002) 5.31
The epidemiology of malignant gastrointestinal stromal tumors: an analysis of 1,458 cases from 1992 to 2000. Am J Gastroenterol (2005) 4.96
Mechanisms of B-cell lymphoma pathogenesis. Nat Rev Cancer (2005) 4.66
Immunoproliferative small intestinal disease associated with Campylobacter jejuni. N Engl J Med (2004) 4.47
Coeliac disease. Lancet (2003) 4.47
Clinical practice. Adenomatous polyps of the colon. N Engl J Med (2006) 4.22
The molecular classification of the clinical manifestations of Crohn's disease. Gastroenterology (2002) 4.20
Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). J Natl Cancer Inst (2006) 4.17
The ABC of APC. Hum Mol Genet (2001) 4.16
The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification. Ann N Y Acad Sci (2004) 4.13
Cigarette smoking and adenomatous polyps: a meta-analysis. Gastroenterology (2007) 3.73
Bacteroides: the good, the bad, and the nitty-gritty. Clin Microbiol Rev (2007) 3.61
The risk of upper gastrointestinal cancer in familial adenomatous polyposis. Gastroenterology (1992) 3.59
Crohn's disease. Lancet (2002) 3.53
Chronic inflammation and oxidative stress in human carcinogenesis. Int J Cancer (2007) 3.45
Molecular mechanisms of alcohol-mediated carcinogenesis. Nat Rev Cancer (2007) 3.36
Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res (1997) 3.36
The prevalence of celiac disease in average-risk and at-risk Western European populations: a systematic review. Gastroenterology (2005) 3.33
Host-bacterial interactions in Helicobacter pylori infection. Gastroenterology (2008) 3.25
Updated population-based review of carcinoid tumors. Ann Surg (2004) 3.21
Obesity and risk of colorectal cancer: a meta-analysis of 31 studies with 70,000 events. Cancer Epidemiol Biomarkers Prev (2007) 3.16
A prospective study of obesity and cancer risk (Sweden). Cancer Causes Control (2001) 3.13
Alcohol and cancer. Lancet Oncol (2006) 3.10
Cancer incidence in a population-based cohort of individuals hospitalized with celiac disease or dermatitis herpetiformis. Gastroenterology (2002) 2.94
Risk of intestinal cancer in inflammatory bowel disease: a population-based study from olmsted county, Minnesota. Gastroenterology (2006) 2.87
Genetics of Crohn disease, an archetypal inflammatory barrier disease. Nat Rev Genet (2005) 2.82
New genes in inflammatory bowel disease: lessons for complex diseases? Lancet (2006) 2.72
Chronic inflammation: a common and important factor in the pathogenesis of neoplasia. CA Cancer J Clin (2006) 2.69
Cytokines and autoimmunity. Nat Rev Immunol (2002) 2.51
Prospective study of fruit and vegetable consumption and incidence of colon and rectal cancers. J Natl Cancer Inst (2000) 2.46
Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma. Ann Intern Med (1997) 2.45
Molecular pathobiology of gastrointestinal stromal sarcomas. Annu Rev Pathol (2008) 2.38
Obesity and cancer risk among white and black United States veterans. Cancer Causes Control (2004) 2.36
The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiota. Clin Microbiol Rev (2006) 2.36
Cigarette smoking and the colorectal adenoma-carcinoma sequence: a hypothesis to explain the paradox. Am J Epidemiol (1998) 2.25
The epidemiology of cancer of the small bowel. Cancer Epidemiol Biomarkers Prev (1998) 2.04
Increased risk for cancer in patients with the Peutz-Jeghers syndrome. Ann Intern Med (1998) 1.96
Increased risk of intestinal cancer in Crohn's disease: a meta-analysis of population-based cohort studies. Am J Gastroenterol (2005) 1.95
Autoimmunity and susceptibility to Hodgkin lymphoma: a population-based case-control study in Scandinavia. J Natl Cancer Inst (2006) 1.90
Investigations on the significance of the adenoma-carcinoma sequence in the small bowel. Cancer (1990) 1.90
STK11/LKB1 Peutz-Jeghers gene inactivation in intraductal papillary-mucinous neoplasms of the pancreas. Am J Pathol (2001) 1.89
Causes of death in patients with celiac disease in a population-based Swedish cohort. Arch Intern Med (2003) 1.88
Risk of malignancy in patients with celiac disease. Am J Med (2003) 1.85
Malignant lymphomas in autoimmunity and inflammation: a review of risks, risk factors, and lymphoma characteristics. Cancer Epidemiol Biomarkers Prev (2006) 1.81
Risk of non-Hodgkin lymphoma in celiac disease. JAMA (2002) 1.81
Gastrointestinal stromal tumors: from a surgical to a molecular approach. Int J Cancer (2003) 1.77
Pathogenesis of adenocarcinoma in Peutz-Jeghers syndrome. Cancer Res (1998) 1.73
Glycans as legislators of host-microbial interactions: spanning the spectrum from symbiosis to pathogenicity. Glycobiology (2001) 1.71
Molecular pathogenesis of multiple gastrointestinal stromal tumors in NF1 patients. Hum Mol Genet (2006) 1.68
The widening spectrum of celiac disease. Am J Clin Nutr (1999) 1.64
Epidemiology of celiac disease: what are the prevalence, incidence, and progression of celiac disease? Gastroenterology (2005) 1.63
Colonic bacterial flora: changing understandings in the molecular age. J Nutr (2004) 1.58
A population-based study of the incidence of malignant small bowel tumours: SEER, 1973-1990. Int J Epidemiol (1996) 1.56
The "normal" endocrine cell of the gut: changing concepts and new evidences. Ann N Y Acad Sci (2004) 1.55
Alpha-heavy chain disease, Mediterranean lymphoma, and immunoproliferative small intestinal disease: a review of clinicopathological features, pathogenesis, and differential diagnosis. Am J Gastroenterol (1999) 1.53
Gastrointestinal stromal tumors and leiomyosarcomas. J Surg Oncol (2008) 1.51
Deoxycholate induces mitochondrial oxidative stress and activates NF-kappaB through multiple mechanisms in HCT-116 colon epithelial cells. Carcinogenesis (2006) 1.50
Risk factors associated with neuroendocrine tumors: A U.S.-based case-control study. Int J Cancer (2008) 1.50
Characteristics of small bowel carcinoma in hereditary nonpolyposis colorectal carcinoma. International Collaborative Group on HNPCC. Cancer (1998) 1.48
Incidence of small bowel cancer in the United States and worldwide: geographic, temporal, and racial differences. Cancer Causes Control (2005) 1.48
Carcinoid tumors of the stomach. Surg Oncol (2003) 1.47
CARCINOGENIC EFFECTS OF CYCAD MEAL AND CYCASIN, METHYLAZOXYMETHANOL GLYCOSIDE, IN RATS AND EFFECTS OF CYCASIN IN GERMFREE RATS. Fed Proc (1965) 1.47
Role of intestinal microflora in chronic inflammation and ulceration of the rat colon. Gut (1994) 1.47
Characterization of epithelial cell shedding from human small intestine. Lab Invest (2006) 1.45
Cancer in Crohn's disease after diversionary surgery. A report of seven carcinomas occurring in excluded bowel. Am J Surg (1978) 1.44
Dietary fiber, vegetables, and colon cancer: critical review and meta-analyses of the epidemiologic evidence. J Natl Cancer Inst (1990) 1.42
The enterohepatic circulation of bile acids in man. Clin Gastroenterol (1977) 1.41
Small bowel cancer: epidemiological and clinical characteristics from a population-based registry. Am J Gastroenterol (1994) 1.39
Celiac disease. Annu Rev Med (2006) 1.35
Epidemiology of adenocarcinomas of the small intestine: is bile a small bowel carcinogen? Br J Cancer (1991) 1.35
The risk of subsequent primary cancers after colorectal cancer in southeast England. Gut (2002) 1.34
HNPCC-associated small bowel cancer: clinical and molecular characteristics. Gastroenterology (2005) 1.32
Risk factors for adenocarcinoma of the small intestine. Int J Cancer (1999) 1.31
Malignancy and mortality in a population-based cohort of patients with coeliac disease or "gluten sensitivity". World J Gastroenterol (2007) 1.30
Risk factors for small intestine cancer. Cancer Causes Control (1993) 1.28
Emerging pathways in the development of AIDS-related lymphomas. Lancet Oncol (2003) 1.27
Genetic background of celiac disease and its clinical implications. Am J Gastroenterol (2008) 1.26
Risk of second cancers in patients with colorectal carcinoids. Dis Colon Rectum (2002) 1.26
Risk factors for adenocarcinomas and malignant carcinoids of the small intestine: preliminary findings. Cancer Epidemiol Biomarkers Prev (1994) 1.26
New concepts in the pathophysiology of inflammatory bowel disease. Ann Intern Med (2005) 1.23
The intestine and its microflora are partners for the protection of the host: report on the Danone Symposium "The Intelligent Intestine," held in Paris, June 14, 2002. Am J Clin Nutr (2003) 1.23
Alcohol consumption and the etiology of colorectal cancer: a review of the scientific evidence from 1957 to 1991. Nutr Cancer (1992) 1.23
Adenocarcinoma of the small intestine in Crohn's disease. Surg Gynecol Obstet (1991) 1.22
Bacterial regulation of intestinal immune responses. Gastroenterol Clin North Am (2005) 1.20
Genetic alterations in sporadic and Crohn's-associated adenocarcinomas of the small intestine. Gastroenterology (1997) 1.17
Familial adenomatous polyposis. Br J Surg (1994) 1.15
CARD15/NOD2 mutations in Crohn's disease. Ann N Y Acad Sci (2006) 1.14
Adenoma-carcinoma sequence in the papilla of Vater. Scand J Gastroenterol (1996) 1.13
Colonic mucosal proliferation is related to serum deoxycholic acid levels. Cancer (1999) 1.12
Rapidly increasing incidence of ocular non-hodgkin lymphoma. J Natl Cancer Inst (2006) 1.10
Inflammatory bowel disease genetics: Nod2. Annu Rev Med (2007) 1.10
Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. J Clin Oncol (2004) 4.71
Race, socioeconomic status and stage at diagnosis for five common malignancies. Cancer Causes Control (2003) 2.88
A combined genomewide linkage scan of 1,233 families for prostate cancer-susceptibility genes conducted by the international consortium for prostate cancer genetics. Am J Hum Genet (2005) 1.96
Recent time trends in the epidemiology of stage IV prostate cancer in the United States: analysis of data from the Surveillance, Epidemiology, and End Results Program. Urology (2009) 1.80
Pooled genome linkage scan of aggressive prostate cancer: results from the International Consortium for Prostate Cancer Genetics. Hum Genet (2006) 1.70
Genome-wide linkage scan for prostate cancer susceptibility from the University of Michigan Prostate Cancer Genetics Project: suggestive evidence for linkage at 16q23. Prostate (2009) 1.10
Current perspective on the global and United States cancer burden attributable to lifestyle and environmental risk factors. Annu Rev Public Health (2013) 1.10
Risk of second primary tumors in men diagnosed with prostate cancer: a population-based cohort study. Cancer (2014) 1.05
Genome-wide linkage scan for prostate cancer susceptibility genes in men with aggressive disease: significant evidence for linkage at chromosome 15q12. Hum Genet (2006) 0.96
The Metabolic Syndrome and Biochemical Recurrence following Radical Prostatectomy. Prostate Cancer (2011) 0.94
Racial differences in breast cancer survival in the Detroit Metropolitan area. Breast Cancer Res Treat (2005) 0.91
Truncating variants in p53AIP1 disrupting DNA damage-induced apoptosis are associated with prostate cancer risk. Cancer Res (2006) 0.86
Advances in cancer epidemiology: understanding causal mechanisms and the evidence for implementing interventions. Annu Rev Public Health (2005) 0.84
Antioxidant micronutrients and the risk of renal cell carcinoma in the Women's Health Initiative cohort. Cancer (2014) 0.83
The Duffy Antigen/Receptor for Chemokines (DARC) and prostate-cancer risk among Jamaican men. J Immigr Minor Health (2011) 0.83
Prevalence and correlates of vitamin and supplement usage among men with a family history of prostate cancer. Integr Cancer Ther (2011) 0.80
Gene-environment interactions between JAZF1 and occupational and household lead exposure in prostate cancer among African American men. Cancer Causes Control (2014) 0.80
Risk of other cancers in individuals with a family history of pancreas cancer. J Gastrointest Cancer (2007) 0.77